Abstract
BackgroundMalaria remains a diagnostic challenge in many endemic communities. Although rapid diagnostic tests (RDTs) are presently widely used for malaria diagnosis, there is a dearth of information on post-marketing surveillance on its efficacy in Cameroon. The present study evaluated the performance characteristics of CareStart™ Malaria HRP2 (histidine-rich protein 2) antigen (Ag) RDT in diagnosing Plasmodium falciparum infection in the Mount Cameroon area and predictors associated with RDT positivity.MethodsThe CareStart™ Malaria HRP2 Plasmodium falciparum (G0141) Ag RDT was evaluated in a cross-sectional community-based survey involving 491 children of both sexes aged 6 months to 14 years between April and May 2018. Malaria parasitaemia was confirmed by light microscopy. Sensitivity (Se), specificity (Sp), positive (PPV) and negative (NPV) predictive values of the RDT, and the corresponding accuracy and Kappa value (κ) were determined using microscopy as the gold standard. Haemoglobin (Hb) concentration was obtained using an auto-haematology analyser. Results were compared using the chi-square test and associations between predictor variables, and RDT results were assessed using logistic regression analysis.ResultsMicroscopically confirmed malaria parasite prevalence was 27.7%, and geometric mean density was 187 parasites/μL of blood (range 70–1162). Se, Sp, PPV, NPV and accuracy were 82.4, 76.6, 57.4, 91.9 and 78.2%, respectively. Sensitivity depended on parasitaemia and reached 96.1% at densities ≥ 200 parasites/μL of blood. The accuracy of malaria parasitaemia (as assessed by the area under the receiver operating characteristic curve) to predict malaria by RDT was 75.4% (95% CI 70.6–80.1). The agreement between microscopy and RDT was moderate (κ = 0.52). RDT positivity was significantly associated with fever (P < 0.001), children less than 5 years (P = 0.02), history of fever within a month (P < 0.001) and anaemia (P = 0.002).ConclusionThe overall concurrence of CareStart™ Malaria HRP2 pf Ag RDT with microscopy in the detection of P. falciparum infection is moderate and is most useful at parasitaemia ≥ 200 parasites/μL of blood and presentation with fever. While RDT is effective as a diagnostic test for confirmation of clinical cases of malaria, its applications in population screening with a higher proportion of asymptomatic cases are limited.
Highlights
Malaria remains a diagnostic challenge in many endemic communities
P. falciparum infection was present in 27.7% of the children, while using Rapid diagnostic tests (RDT), malaria was diagnosed in 39.7% of participants
Findings from this study demonstrated a higher CareStart RDT (G0141) performance characteristics when compared with a previous study carried out by Ndamukong-Nyanga [21] in the Mount Cameroon area even though their mean parasite density/μL of blood (2333, range 18–16,000) was higher
Summary
Malaria remains a diagnostic challenge in many endemic communities. rapid diagnostic tests (RDTs) are presently widely used for malaria diagnosis, there is a dearth of information on post-marketing surveillance on its efficacy in Cameroon. The current control strategies adopted by the National Malaria Control Program (NMCP) in Cameroon include the intermittent preventive treatment in pregnant women, free treatment of uncomplicated malaria in children under five with artemisinin-based combination therapies (ACTs), indoor residual spraying and more recently free distribution of long-lasting insecticidal nets [1]. Despite these control measures put in place in Cameroon, malaria remains the major cause of morbidity and mortality, with over 90% of the population at risk of the disease [6], accounting for about 48% of all hospital admissions and 30% of all hospital deaths [7]. Malaria can be diagnosed in several ways which include presumptive diagnosis using the signs and symptoms associated with it, demonstration of the parasite, its parts or soluble products in body fluids such as Plasmodium falciparum histidine-rich protein 2 (PfHRP2), that can be captured by monoclonal antibodies raised against these antigens in the form of a RDT [12]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
